RAF/MEK/mTOR inhibitors were among the top-ranked hits with suggested positive treatment effects on HR + BC of the young—being in line with our finding of gene expression patterns reflecting increased oncogenic signalling in tumours of the young. Here, MAP2K7 is linked to breast cancer.